Charlie Newton

Charlie Newton has served as a member of our Board of Directors since May 2022. Mr. Newton is the Chief Financial Officer of Lyell Immunopharma, a publicly traded biotechnology company. Prior to joining Lyell, he served as Managing Director & Co-Head of Healthcare Investment Banking in the Americas at BofA Securities, Managing Director & Co-Head of Healthcare Investment Banking in the Americas at Credit Suisse, and Managing Director & Head of Western Region Healthcare Investment Banking at Morgan Stanley. Mr. Newton advised on approximately $200 billion in mergers and acquisitions and raised nearly $60 billion in capital during his investment banking career. Mr. Newton earned a M.B.A. from the Tuck School at Dartmouth College as well as a B.S. in Finance from Miami University.